Tick (check) box to add article to PDF "basket"
If doctors use genetic testing to assess the likelihood of patients developing a certain disease, they need to be sure that the results are accurate. In pre-natal testing, there is only one chance to get it right. An EU-funded project has vastly improved the entire testing process, ensuring patients have all the facts.
Published: 23 November 2015
Breast cancer is the leading cause of cancer deaths in women, with more than one million cases diagnosed in the world every year. The EU-funded BASIS project has reached a major milestone in characterising the different genetic mutations that lie behind this disease - defining the range of possibilities for drug development.
Published: 1 October 2015
An international team of researchers, led by ERC grantee Prof Rune Linding, discovered how genetic cancer mutations attack the networks controlling human cells. This knowledge is critical for the future development of personalized precision cancer treatments.
Published: 1 October 2015
In Europe, some 463 000 women are diagnosed with breast cancer each year, making it the most common form of cancer in women. Depending on certain conditions, different drug combinations will be more - or less - effective. The EU-funded RESPONSIFY project has identified these conditions.
Published: 16 July 2015
Cellular regeneration allows wound healing in humans but in other vertebrates such as salamanders, it goes a step further: they can regenerate their limbs in their full complexity of bones, nerves, muscle and skin and can do it over and over again. Prof. Elly Tanaka studies these amazing capacities and, mirroring the process, has successfully grown a piece of mouse spinal cord in vitro.
Published: 17 June 2015
The decoding of our genetic material has opened up new frontiers in clinical care. Now a landmark EU-funded project has developed cutting edge DNA sequencing that could make cancer diagnosis and treatment significantly more effective and affordable - helping to save lives.
Published: 21 April 2015
An internal clock determines many of our bodily functions. The same is true for tumour cells, EU-funded research suggests. This discovery could point the way to a more efficient, personalised approach to cancer treatment.
Published: 20 February 2015
Published: 21 January 2015
EpiPGX is a FP7-funded project that brings together clinical researchers, geneticists and computational biologists from leading centres across Europe to link genomics and treatment outcomes for patients suffering from epileptic seizures. The project, led by Prof. Sanjay Sisodiya from the University College London, UK and running over four years, aims to ultimately contribute to a personalised medicine strategy for epilepsy patients.
Published: 20 November 2014
The European FP7 project DeCanbio brought together a consortium of clinicians and researchers in genomics, proteomics and bioinformatics to identify and validate biomarkers that hint at a recurring bladder cancer. The Centre de Recherche de la Santé (CRP-Santé) joined forces with researchers and clinicians from France, Spain, Greece, Switzerland, and Germany to develop a simple test to spot this.
Published: 25 July 2014